Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act, 24037-24038 [2024-07269]
Download as PDF
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Notices
Tennessee Department of Health
License Verification, https://
apps.health.tn.gov/Licensure/
default.aspx (last visited date of
signature of this Order); Virginia
Department of Health Professions
License Lookup, https://dhp.virginia
interactive.org/lookup (last visited date
of signature of this Order).
Accordingly, the Agency finds that
Respondent is not currently licensed to
practice medicine in either Tennessee or
Virginia, the states in which he is
registered with the DEA.5
khammond on DSKJM1Z7X2PROD with NOTICES
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of the Controlled
Substances Act (CSA) ‘‘upon a finding
that the registrant . . . has had his State
license or registration suspended . . .
[or] revoked . . . by competent State
authority and is no longer authorized by
State law to engage in the . . .
dispensing of controlled substances.’’
With respect to a practitioner, the DEA
has also long held that the possession of
authority to dispense controlled
substances under the laws of the state in
which a practitioner engages in
professional practice is a fundamental
condition 6 for obtaining and
maintaining a practitioner’s registration.
See, e.g., James L. Hooper, M.D., 76 FR
71371, 71372 (2011), pet. for rev.
denied, 481 F. App’x 826 (4th Cir.
2012); Frederick Marsh Blanton, M.D.,
43 FR 27616, 27617 (1978).7
email to the other party and to Office of the
Administrator, Drug Enforcement Administration at
dea.addo.attorneys@dea.gov.
5 Because Respondent’s DEA registrations at issue
here are based on his Tennessee and Virginia
medical licenses, which have undeniably been
revoked and suspended, it is of no consequence that
he may maintain a valid medical license and
separate DEA registration based in North Carolina,
see Respondent’s Opposition, at 4. RD, at 7; Omar
Garcia, M.D., 87 FR 32186, 32187 n.6 (2022).
6 As such, the Agency finds Respondent’s
arguments regarding the discretionary nature of 21
U.S.C. 824(a)(3), see Respondent’s Response in
Opposition to Government’s Motion for Summary
Disposition (Respondent’s Opposition), at 4, to be
unavailing. RD, at 6; see also Bhanoo Sharma, M.D.,
87 FR 41355, 41356 n.4 (2022).
7 This rule derives from the text of two provisions
of the CSA. First, Congress defined the term
‘‘practitioner’’ to mean ‘‘a physician . . . or other
person licensed, registered, or otherwise permitted,
by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a
controlled substance in the course of professional
practice.’’ 21 U.S.C. 802(21). Second, in setting the
requirements for obtaining a practitioner’s
registration, Congress directed that ‘‘[t]he Attorney
General shall register practitioners . . . if the
applicant is authorized to dispense . . . controlled
substances under the laws of the State in which he
practices.’’ 21 U.S.C. 823(g)(1) (this section,
formerly § 823(f), was redesignated as part of the
Medical Marijuana and Cannabidiol Research
VerDate Sep<11>2014
16:44 Apr 04, 2024
Jkt 262001
According to Tennessee statute,
‘‘dispense’’ means ‘‘to deliver a
controlled substance to an ultimate user
or research subject by or pursuant to the
lawful order of a practitioner, including
the prescribing, administering,
packaging, labeling, or compounding
necessary to prepare the substance for
that delivery’’; a ‘‘practitioner’’ means a
‘‘physician . . . or other person
licensed, registered or otherwise
permitted to distribute, dispense,
conduct research with respect to or to
administer a controlled substance in the
course of professional practice or
research in [the] state.’’ Tenn. Code
Ann. § 39–17–402(7), (23)(A) (West
2024). Similarly, under Virginia statute,
‘‘dispense’’ means ‘‘to deliver a drug to
an ultimate user or research subject by
or pursuant to the lawful order of a
practitioner, including the prescribing
and administering, packaging, labeling,
or compounding necessary to prepare
the substance for that delivery’’; a
‘‘practitioner’’ means a ‘‘physician . . .
or other person licensed, registered, or
otherwise permitted to distribute,
dispense, prescribe and administer, or
conduct research with respect to a
controlled substance in the course of
professional practice or research in the
[state].’’ Va. Code Ann. § 54.1–3401
(West 2023).
Here, the undisputed evidence in the
record is that Respondent lacks
authority to practice medicine in both
Tennessee and Virginia. As discussed
above, in both Tennessee and Virginia,
a physician must be a licensed
practitioner to dispense a controlled
substance. Thus, because Respondent
Expansion Act, Pub. L. 117–215, 136 Stat. 2257
(2022)). Because Congress has clearly mandated that
a practitioner possess state authority in order to be
deemed a practitioner under the CSA, the DEA has
held repeatedly that revocation of a practitioner’s
registration is the appropriate sanction whenever he
is no longer authorized to dispense controlled
substances under the laws of the state in which he
practices. See, e.g., James L. Hooper, 76 FR at
71371–72; Sheran Arden Yeates, M.D., 71 FR
39130, 39131 (2006); Dominick A. Ricci, M.D., 58
FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR
11919, 11920 (1988); Frederick Marsh Blanton, 43
FR at 27617. Moreover, because ‘‘the controlling
question’’ in a proceeding brought under 21 U.S.C.
824(a)(3) is whether the holder of a practitioner’s
registration ‘‘is currently authorized to handle
controlled substances in the [S]tate,’’ Hooper, 76 FR
at 71371 (quoting Anne Lazar Thorn, 62 FR 12847,
12848 (1997)), the Agency has also long held that
revocation is warranted even where a practitioner
is still challenging the underlying action. Bourne
Pharmacy, 72 FR 18273, 18274 (2007); Wingfield
Drugs, 52 FR 27070, 27071 (1987). Thus, it is of no
consequence that Respondent is still challenging
the underlying action here, see Respondent’s
Opposition, at 4. RD, at 6–7. What is consequential
is the Agency’s finding that Respondent is not
currently authorized to dispense controlled
substances in either Tennessee or Virginia, the
states in which he is registered with the DEA. Adley
Dasilva, P.A., 87 FR 69341, 69341 n.2 (2022).
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
24037
lacks authority to practice medicine in
both Tennessee and Virginia and,
therefore is not authorized to handle
controlled substances in either
Tennessee or Virginia, Respondent is
not eligible to maintain a DEA
registration in those states. RD, at 6–7.
Accordingly, the Agency will order the
Respondent’s DEA registrations be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificates
of Registration Nos. FR0673548 and
FR0004589 issued to Ralph Reach, M.D.
Further, pursuant to 28 CFR 0.100(b)
and the authority vested in me by 21
U.S.C. 823(g)(1), I hereby deny any
pending applications of Ralph Reach,
M.D., to renew or modify these
registrations, as well as any other
pending application of Ralph Reach,
M.D., for additional registration in
Tennessee or Virginia. This Order is
effective May 6, 2024.
Signing Authority
This document of the Drug
Enforcement Administration was signed
on April 1, 2024, by Administrator
Anne Milgram. That document with the
original signature and date is
maintained by DEA. For administrative
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DEA Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
DEA. This administrative process in no
way alters the legal effect of this
document upon publication in the
Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2024–07236 Filed 4–4–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
On April 1, 2024, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Western District of New
York in the lawsuit entitled U.S. v.
Kyocera AVX Components Corporation,
Civil No. 1:24–cv–305.
E:\FR\FM\05APN1.SGM
05APN1
24038
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Notices
In this action, the United States seeks,
pursuant to the Comprehensive
Environmental Response,
Compensation, and Liability Act
(‘‘CERCLA’’), 42 U.S.C. 9601, et seq.,
injunctive relief and recovery of
response costs regarding the Olean
Wellfield Superfund Site in the City of
Olean, the Town of Olean, and the
Town of Portville, New York (the
‘‘Site’’). The proposed Consent Decree
will require the Kyocera AVX
Components Corporation (‘‘KAVX’’) to
perform the ‘‘Operable Unit 5’’ (‘‘OU5’’)
remedial action at the Site, and to
reimburse the U.S. Environmental
Protection Agency for its past and future
costs regarding the OU5 remedial
action. The OU5 remedial action
comprises the performance of a soil
cleanup at a parcel of property owned
by KAVX.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
U.S. v. Kyocera AVX Components
Corporation, D.J. Ref. No. 90–11–3–181/
2. All comments must be submitted no
later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
khammond on DSKJM1Z7X2PROD with NOTICES
By mail .........
Any comments submitted in writing
may be filed in whole or in part on the
public court docket without notice to
the commenter.
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
Consent Decree, you may request
assistance by email or by mail to the
addresses provided above for submitting
comments.
Henry Friedman,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–07269 Filed 4–4–24; 8:45 am]
BILLING CODE 4410–15–P
VerDate Sep<11>2014
16:44 Apr 04, 2024
Jkt 262001
Veterans’ Employment and Training
Service
Advisory Committee on Veterans’
Employment, Training and Employer
Outreach (ACVETEO): Meeting
Veterans’ Employment and
Training Service (VETS), Department of
Labor (DOL).
ACTION: Notice of open meeting.
AGENCY:
This notice sets forth the
schedule and proposed agenda of a
forthcoming meeting of the ACVETEO.
The ACVETEO will discuss the DOL
core programs and services that assist
veterans seeking employment and raise
employer awareness as to the
advantages of hiring veterans. There
will be an opportunity for individuals or
organizations to address the committee.
Any individual or organization that
wishes to do so should contact Mr.
Gregory Green at ACVETEO@dol.gov.
Additional information regarding the
Committee, including its charter,
current membership list, annual reports,
meeting minutes, and meeting updates
may be found at https://www.dol.gov/
agencies/vets/about/advisorycommittee.
This notice also describes the functions
of the ACVETEO. This document is
intended to notify the general public.
DATES: Tuesday, April 23, 2024
beginning at 9 a.m. and ending at
approximately 12 p.m. (EDT).
ADDRESSES: This ACVETEO meeting
will be held via TEAMS and
teleconference. Meeting information
will be posted at the link below under
the Meeting Updates tab. https://
www.dol.gov/agencies/vets/about/
advisorycommittee.
Notice of Intent to Attend the Meeting:
All meeting participants should submit
a notice of intent to attend by Friday,
April 19, 2024, via email to Mr. Gregory
Green at ACVETEO@dol.gov, subject
line ‘‘April 2024 ACVETEO Meeting.’’
Individuals who will need
accommodations for a disability in order
to attend the meeting (e.g., interpreting
services, assistive listening devices,
and/or materials in alternative format)
should notify the Advisory Committee
no later than Friday, April 19, 2024, by
contacting Mr. Gregory Green at
ACVETEO@dol.gov.
Requests made after this date will be
reviewed, but availability of the
requested accommodations cannot be
guaranteed.
FOR FURTHER INFORMATION CONTACT: Mr.
Gregory Green, Designated Federal
Official for the ACVETEO, ACVETEO@
dol.gov, (202) 693–4734.
SUMMARY:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
The
ACVETEO is a Congressionally
mandated advisory committee
authorized under title 38, U.S. Code,
section 4110 and subject to the Federal
Advisory Committee Act, 5 U.S.C. 10.
The ACVETEO is responsible for:
assessing employment and training
needs of veterans; determining the
extent to which the programs and
activities of the U.S. Department of
Labor meet these needs; assisting to
conduct outreach to employers seeking
to hire veterans; making
recommendations to the Secretary,
through the Assistant Secretary for
Veterans’ Employment and Training
Service, with respect to outreach
activities and employment and training
needs of veterans; and carrying out such
other activities necessary to make
required reports and recommendations.
The ACVETEO meets at least quarterly.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF LABOR
Agenda
9:00 a.m. Welcome and remarks, James
D. Rodriguez, Assistant Secretary,
Veterans’ Employment and Training
Service
9:05 a.m. Administrative Business,
Gregory Green, Designated Federal
Official
9:15 a.m. Briefing on Apprenticeships
9:45 a.m. Briefing on Partnerships
10:15 a.m. Break
10:30 a.m. Briefing on Grants
11:00 a.m. Briefing on Military
Spouse/USERRA
11:30 a.m. Public Forum, Gregory
Green, Designated Federal Official
12:00 p.m. Adjourn
Signed in Washington, DC, this 1st day of
April 2024.
James D. Rodriguez,
Assistant Secretary, Veterans’ Employment
and Training Service.
[FR Doc. 2024–07206 Filed 4–4–24; 8:45 am]
BILLING CODE 4510–79–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: 024–028]
NASA Advisory Council; STEM
Engagement Committee; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, as
amended, the National Aeronautics and
Space Administration announces a
meeting of the Science, Technology,
Engineering and Mathematics (STEM)
Engagement Committee of the NASA
SUMMARY:
E:\FR\FM\05APN1.SGM
05APN1
Agencies
[Federal Register Volume 89, Number 67 (Friday, April 5, 2024)]
[Notices]
[Pages 24037-24038]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07269]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed Consent Decree Under the
Comprehensive Environmental Response, Compensation, and Liability Act
On April 1, 2024, the Department of Justice lodged a proposed
Consent Decree with the United States District Court for the Western
District of New York in the lawsuit entitled U.S. v. Kyocera AVX
Components Corporation, Civil No. 1:24-cv-305.
[[Page 24038]]
In this action, the United States seeks, pursuant to the
Comprehensive Environmental Response, Compensation, and Liability Act
(``CERCLA''), 42 U.S.C. 9601, et seq., injunctive relief and recovery
of response costs regarding the Olean Wellfield Superfund Site in the
City of Olean, the Town of Olean, and the Town of Portville, New York
(the ``Site''). The proposed Consent Decree will require the Kyocera
AVX Components Corporation (``KAVX'') to perform the ``Operable Unit
5'' (``OU5'') remedial action at the Site, and to reimburse the U.S.
Environmental Protection Agency for its past and future costs regarding
the OU5 remedial action. The OU5 remedial action comprises the
performance of a soil cleanup at a parcel of property owned by KAVX.
The publication of this notice opens a period for public comment on
the Consent Decree. Comments should be addressed to the Assistant
Attorney General, Environment and Natural Resources Division, and
should refer to U.S. v. Kyocera AVX Components Corporation, D.J. Ref.
No. 90-11-3-181/2. All comments must be submitted no later than thirty
(30) days after the publication date of this notice. Comments may be
submitted either by email or by mail:
------------------------------------------------------------------------
To submit comments: Send them to:
------------------------------------------------------------------------
By email............................ [email protected].
By mail............................. Assistant Attorney General, U.S.
DOJ--ENRD, P.O. Box 7611,
Washington, DC 20044-7611.
------------------------------------------------------------------------
Any comments submitted in writing may be filed in whole or in part
on the public court docket without notice to the commenter.
During the public comment period, the Consent Decree may be
examined and downloaded at this Justice Department website: https://www.justice.gov/enrd/consent-decrees. If you require assistance
accessing the Consent Decree, you may request assistance by email or by
mail to the addresses provided above for submitting comments.
Henry Friedman,
Assistant Section Chief, Environmental Enforcement Section, Environment
and Natural Resources Division.
[FR Doc. 2024-07269 Filed 4-4-24; 8:45 am]
BILLING CODE 4410-15-P